ストックスクリーナーアプリを入手
39.41
0.10%
0.04
アフターアワーズ：
39.41
Immunovant Inc (IMVT) 最新ニュース
Immunovant CFO Tiago Girao sells $263,014 in company stock By Investing.com - Investing.com Nigeria
Immunovant director Atul Pande sells $59,699 in shares By Investing.com - Investing.com Canada
Immunovant director Atul Pande sells $59,699 in shares - Investing.com
Form 4 Immunovant Inc For: 24 July By Investing.com - Investing.com Nigeria
Immunovant CFO Tiago Girao sells $263,014 in company stock - Investing.com
Immunovant CTO Jay Stout sells $110,537 in shares - Investing.com
Immunovant CTO Jay Stout Executes Share Sale to Meet Tax Obligations Post-RSU Vesting - Kalkine Media
Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026 - The Manila Times
Immunovant, Inc. ($IMVT) CEO 2026 Pay Revealed - Quiver Quantitative
Immunovant, Inc. SEC Filing (Jul 22, 2026) - Stock Titan
Law firm investigates Immunovant officers for p... - Pluang
Understanding Momentum Shifts in (IMVT) - Stock Traders Daily
Immunovant Inc. (IMVT) Q2 2026 Earnings: Wider-than-Expected Loss Highlights Ongoing R&D InvestmentOne-Time Loss Impact - dars.gov.et
Immunovant chief legal officer Van Tuyl sells $47,702 in stock By Investing.com - Investing.com India
Immunovant CTO Jay Stout sells $137,924 in IMVT stock - Investing.com
Immunovant CTO Jay Stout sells $137,924 in IMVT stock By Investing.com - Investing.com South Africa
Form 4 Immunovant Inc For: 10 July By Investing.com - Investing.com Nigeria
Immunovant chief legal officer Van Tuyl sells $47,702 in stock - Investing.com
Immunovant COO Melanie Gloria sells $80,531 in shares By Investing.com - Investing.com South Africa
Immunovant COO Melanie Gloria sells $80,531 in shares - Investing.com
Immunovant (IMVT) COO offloads 2,036 shares to cover RSU tax withholding - Stock Titan
Immunovant (IMVT) legal chief sells 1,206 shares in tax “sell to cover” - Stock Titan
Immunovant (IMVT) CTO offloads 3,487 shares in mandated RSU tax-withholding sales - Stock Titan
LifeSci Capital Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $53 - Moomoo
Emerging Therapies Transforming the Myasthenia Gravis Market by DelveInsight | Sanofi, Cartesian Therapeutics, Takeda, UCB Biopharma, Roche, Janssen R&D, Immunovant Sciences GmbH, Argenx-Halozyme - Barchart.com
Immunovant Inc explores long term growth paths as autoimmune pipeline advances - Ad-hoc-news.de
Immunovant stock hits 52-week high at 39.28 USD By Investing.com - Investing.com South Africa
Immunovant stock hits 52-week high at 39.28 USD - Investing.com
Immunovant Inc outlines its autoimmune drug pipeline as investors watch clinical milestones - AD HOC NEWS
Form 4 Immunovant Inc For: 6 July By Investing.com - Investing.com Nigeria
Immunovant CEO Eric Venker sells $118,980 of IMVT stock - Investing.com UK
Immunovant CEO Eric Venker sells $118,980 of IMVT stock By Investing.com - Investing.com Nigeria
Immunovant (IMVT) CEO settles CVARs with small tax-related share sale - Stock Titan
All You Need to Know About Immunovant (IMVT) Rating Upgrade to Buy - MSN
IMVTImmunovant Inc Earnings - Finviz
Chief Technology Officer Of Immunovant Sold 53% Of Their Shares - Sahm
Immunovant (IMVT) up 3.6% since last earnings report: Can it continue? - MSN
IMVT Maintained by Citigroup -- Price Target Raised to $61.00 - GuruFocus
Immunovant Insider Sold Shares Worth $1,532,309, According to a Recent SEC Filing - Moomoo
Citi Maintains Immunovant(IMVT.US) With Buy Rating, Raises Target Price to $61 - Moomoo
Immunovant COO Melanie Gloria sells $678k in company stock By Investing.com - Investing.com India
Immunovant CFO Tiago Girao sells $384,600 in company stock By Investing.com - Investing.com Nigeria
0.46%
0.84%
大文字化:
|
ボリューム (24 時間):